Advantages of Point of Care Lung Function Testing in Interstitial Lung Disease (ILD)
Hear from the Founder of the Interstitial Lung Disease (ILD) program at UT Health San Antonio, Dr. Anoop M. Nambiar, MD, MS, as he discusses the importance of DLCO in ILD. \*Due to the COVID-19 pandemic, webinar date & time may change.
What you will learn #
- The importance of DLCO testing in ILD.
- Learn why point of care pulmonary devices makes testing more convenient for the patient & provider.
- Hear about ndd’s proven TrueFlow & TrueCheck technologies.